RecallDepth
Class II Ongoing

Dabigatran Etexilate, 75 mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-474-60

This recall is currently active, issued December 18, 2024. It was issued by Ascend Laboratories, Llc.

Company
Ascend Laboratories, Llc
Recall Initiated
December 12, 2024
Posted
December 18, 2024
Recall Number
D-0129-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1971 bottles
Firm Location
Parsippany, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit

Distribution

Nationwide within the United States

Lot / Code Info

Lot #: 24142328, 24142329, 24142330, Exp. Date May 31, 2026.

More recalls by Ascend Laboratories, Llc

View all recalls by this company →

Other recent Class II Drug recalls